Hatice Hasturk, D.D.S., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Periodontitis | 44 | 2024 | 559 | 6.170 |
Why?
|
| Gingivitis | 9 | 2023 | 124 | 3.810 |
Why?
|
| Alveolar Bone Loss | 13 | 2023 | 390 | 1.770 |
Why?
|
| Eicosapentaenoic Acid | 14 | 2022 | 560 | 1.620 |
Why?
|
| Periodontal Diseases | 9 | 2024 | 451 | 1.500 |
Why?
|
| Porphyromonas gingivalis | 15 | 2023 | 162 | 1.460 |
Why?
|
| Lipoxins | 10 | 2021 | 419 | 1.280 |
Why?
|
| Chronic Periodontitis | 12 | 2021 | 101 | 1.220 |
Why?
|
| Periodontal Ligament | 7 | 2023 | 117 | 1.090 |
Why?
|
| Dental Plaque | 8 | 2021 | 209 | 1.080 |
Why?
|
| Complement C3 | 4 | 2022 | 451 | 1.030 |
Why?
|
| Inflammation | 27 | 2024 | 10746 | 1.000 |
Why?
|
| Neutrophils | 23 | 2021 | 3764 | 0.870 |
Why?
|
| Polyanhydrides | 2 | 2014 | 5 | 0.850 |
Why?
|
| Calcium Hydroxide | 2 | 2014 | 16 | 0.840 |
Why?
|
| Saliva | 10 | 2024 | 827 | 0.820 |
Why?
|
| Bone Substitutes | 3 | 2014 | 236 | 0.800 |
Why?
|
| Diabetes Complications | 3 | 2020 | 1317 | 0.780 |
Why?
|
| Polymethyl Methacrylate | 2 | 2014 | 131 | 0.780 |
Why?
|
| Mouth | 3 | 2024 | 380 | 0.760 |
Why?
|
| Guided Tissue Regeneration, Periodontal | 2 | 2021 | 152 | 0.740 |
Why?
|
| Bacteroidaceae Infections | 5 | 2019 | 31 | 0.720 |
Why?
|
| Amnion | 1 | 2021 | 197 | 0.680 |
Why?
|
| Peptides, Cyclic | 1 | 2021 | 392 | 0.670 |
Why?
|
| Gingival Crevicular Fluid | 6 | 2021 | 94 | 0.650 |
Why?
|
| Inflammation Mediators | 10 | 2024 | 1886 | 0.590 |
Why?
|
| Dental Implants | 4 | 2015 | 793 | 0.580 |
Why?
|
| Aggressive Periodontitis | 7 | 2015 | 59 | 0.580 |
Why?
|
| Docosahexaenoic Acids | 10 | 2022 | 908 | 0.580 |
Why?
|
| Fatty Acids, Monounsaturated | 2 | 2009 | 190 | 0.570 |
Why?
|
| Polyhydroxyethyl Methacrylate | 2 | 2014 | 30 | 0.550 |
Why?
|
| Administration, Topical | 6 | 2021 | 703 | 0.520 |
Why?
|
| Dental Plaque Index | 6 | 2021 | 95 | 0.510 |
Why?
|
| Tooth Socket | 2 | 2014 | 131 | 0.500 |
Why?
|
| Diet, Atherogenic | 1 | 2015 | 93 | 0.500 |
Why?
|
| Diabetes Mellitus, Type 2 | 14 | 2024 | 12127 | 0.470 |
Why?
|
| Cytokines | 18 | 2024 | 7377 | 0.460 |
Why?
|
| Periodontal Index | 6 | 2021 | 151 | 0.440 |
Why?
|
| Superoxides | 10 | 2013 | 386 | 0.430 |
Why?
|
| Osteogenesis | 7 | 2023 | 1273 | 0.430 |
Why?
|
| Dental Abutments | 1 | 2013 | 102 | 0.420 |
Why?
|
| Diabetes Mellitus | 8 | 2024 | 5835 | 0.420 |
Why?
|
| Diabetic Foot | 2 | 2013 | 380 | 0.410 |
Why?
|
| Periodontal Attachment Loss | 6 | 2019 | 144 | 0.410 |
Why?
|
| Tissue Engineering | 1 | 2021 | 1870 | 0.380 |
Why?
|
| Dental Prosthesis Retention | 1 | 2011 | 34 | 0.380 |
Why?
|
| Wound Healing | 5 | 2021 | 2799 | 0.370 |
Why?
|
| Titanium | 1 | 2013 | 484 | 0.360 |
Why?
|
| Rabbits | 8 | 2017 | 4780 | 0.350 |
Why?
|
| Fatty Alcohols | 1 | 2009 | 22 | 0.340 |
Why?
|
| Gingiva | 6 | 2023 | 407 | 0.340 |
Why?
|
| Gingival Diseases | 1 | 2009 | 36 | 0.330 |
Why?
|
| Random Allocation | 5 | 2015 | 2388 | 0.320 |
Why?
|
| Neutrophil Infiltration | 2 | 2023 | 387 | 0.290 |
Why?
|
| Anti-Inflammatory Agents | 6 | 2024 | 1807 | 0.280 |
Why?
|
| Cimetidine | 1 | 2006 | 76 | 0.270 |
Why?
|
| Osteoclasts | 3 | 2012 | 711 | 0.270 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2014 | 2272 | 0.260 |
Why?
|
| Dental Scaling | 7 | 2014 | 104 | 0.260 |
Why?
|
| Mandible | 4 | 2014 | 753 | 0.260 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 1689 | 0.250 |
Why?
|
| Alveolar Process | 4 | 2019 | 294 | 0.250 |
Why?
|
| Biofilms | 4 | 2020 | 627 | 0.250 |
Why?
|
| Periodontal Pocket | 7 | 2014 | 167 | 0.250 |
Why?
|
| Dental Caries | 2 | 2023 | 421 | 0.250 |
Why?
|
| Homeostasis | 2 | 2024 | 3320 | 0.240 |
Why?
|
| Histamine H2 Antagonists | 1 | 2006 | 166 | 0.240 |
Why?
|
| Klebsiella | 1 | 2024 | 51 | 0.240 |
Why?
|
| Autophagy | 2 | 2024 | 1319 | 0.230 |
Why?
|
| Mouthwashes | 2 | 2004 | 57 | 0.230 |
Why?
|
| Swine, Miniature | 4 | 2015 | 961 | 0.230 |
Why?
|
| Diacylglycerol Kinase | 3 | 2013 | 48 | 0.230 |
Why?
|
| Humans | 106 | 2024 | 760437 | 0.220 |
Why?
|
| Metronidazole | 5 | 2013 | 232 | 0.210 |
Why?
|
| Dental Pulp | 1 | 2023 | 84 | 0.210 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2024 | 1841 | 0.210 |
Why?
|
| Group VI Phospholipases A2 | 2 | 2014 | 16 | 0.210 |
Why?
|
| Bacteria | 6 | 2023 | 2217 | 0.210 |
Why?
|
| Atherosclerosis | 2 | 2017 | 3407 | 0.210 |
Why?
|
| Phagocytosis | 4 | 2016 | 1536 | 0.210 |
Why?
|
| Osseointegration | 3 | 2014 | 274 | 0.210 |
Why?
|
| Monocytes | 8 | 2013 | 2572 | 0.200 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2022 | 151 | 0.200 |
Why?
|
| Interleukin-8 | 4 | 2016 | 696 | 0.200 |
Why?
|
| Male | 69 | 2024 | 360035 | 0.200 |
Why?
|
| X-Ray Microtomography | 3 | 2014 | 450 | 0.200 |
Why?
|
| Regeneration | 2 | 2021 | 1508 | 0.200 |
Why?
|
| Oxygen | 1 | 2013 | 4222 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2022 | 3486 | 0.190 |
Why?
|
| Immediate Dental Implant Loading | 2 | 2014 | 66 | 0.190 |
Why?
|
| Actinobacteria | 1 | 2021 | 59 | 0.190 |
Why?
|
| Animals | 31 | 2023 | 168253 | 0.190 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2021 | 344 | 0.190 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2021 | 119 | 0.180 |
Why?
|
| Placebos | 3 | 2021 | 1661 | 0.180 |
Why?
|
| Surface Properties | 2 | 2014 | 1160 | 0.180 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2013 | 944 | 0.170 |
Why?
|
| Adult | 43 | 2024 | 220781 | 0.170 |
Why?
|
| Alveolar Ridge Augmentation | 2 | 2014 | 208 | 0.170 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2024 | 587 | 0.170 |
Why?
|
| Disease Models, Animal | 13 | 2022 | 18216 | 0.170 |
Why?
|
| Periodontium | 3 | 2022 | 97 | 0.170 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2019 | 48 | 0.170 |
Why?
|
| B-Lymphocytes | 5 | 2010 | 4748 | 0.170 |
Why?
|
| Gingival Overgrowth | 2 | 2010 | 7 | 0.170 |
Why?
|
| Oxidation-Reduction | 2 | 2024 | 2227 | 0.160 |
Why?
|
| Symbiosis | 1 | 2021 | 294 | 0.160 |
Why?
|
| Cells, Cultured | 15 | 2023 | 18955 | 0.160 |
Why?
|
| Amoxicillin | 4 | 2013 | 180 | 0.160 |
Why?
|
| Mitochondria | 2 | 2023 | 3624 | 0.160 |
Why?
|
| Chemotaxis, Leukocyte | 5 | 2009 | 664 | 0.150 |
Why?
|
| Acid Ceramidase | 1 | 2017 | 21 | 0.150 |
Why?
|
| Esthetics, Dental | 1 | 2020 | 268 | 0.150 |
Why?
|
| Th17 Cells | 2 | 2023 | 792 | 0.150 |
Why?
|
| Fibromatosis, Gingival | 3 | 2007 | 7 | 0.150 |
Why?
|
| Lymphocyte Activation | 4 | 2021 | 5491 | 0.150 |
Why?
|
| Double-Blind Method | 7 | 2021 | 12320 | 0.140 |
Why?
|
| Female | 59 | 2024 | 391875 | 0.140 |
Why?
|
| Obesity | 6 | 2024 | 12918 | 0.140 |
Why?
|
| Complement Activation | 1 | 2019 | 452 | 0.140 |
Why?
|
| Middle Aged | 37 | 2024 | 220382 | 0.140 |
Why?
|
| Fibroblasts | 6 | 2022 | 4106 | 0.140 |
Why?
|
| Interleukin-17 | 2 | 2021 | 907 | 0.140 |
Why?
|
| Toll-Like Receptors | 2 | 2010 | 589 | 0.130 |
Why?
|
| C-Reactive Protein | 5 | 2022 | 3822 | 0.130 |
Why?
|
| Swine | 4 | 2015 | 5915 | 0.130 |
Why?
|
| Blood-Borne Pathogens | 1 | 2015 | 52 | 0.130 |
Why?
|
| Interleukin-6 | 4 | 2022 | 3209 | 0.130 |
Why?
|
| Glucose | 3 | 2017 | 4342 | 0.130 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2021 | 3759 | 0.120 |
Why?
|
| Fusobacterium nucleatum | 1 | 2016 | 179 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2019 | 1183 | 0.120 |
Why?
|
| Hyperglycemia | 2 | 2022 | 1371 | 0.120 |
Why?
|
| Light-Curing of Dental Adhesives | 1 | 2014 | 4 | 0.120 |
Why?
|
| Intracellular Fluid | 2 | 2005 | 201 | 0.120 |
Why?
|
| Interleukin-1beta | 5 | 2014 | 997 | 0.120 |
Why?
|
| RNA, Ribosomal, 16S | 4 | 2023 | 1037 | 0.110 |
Why?
|
| Lipid A | 1 | 2013 | 70 | 0.110 |
Why?
|
| Overweight | 2 | 2023 | 2412 | 0.110 |
Why?
|
| Drug Administration Schedule | 1 | 2021 | 4849 | 0.110 |
Why?
|
| Chemokine CCL2 | 1 | 2016 | 604 | 0.110 |
Why?
|
| Bone Density Conservation Agents | 2 | 2019 | 795 | 0.110 |
Why?
|
| Pyridones | 1 | 2019 | 807 | 0.110 |
Why?
|
| Interleukin-12 | 1 | 2016 | 583 | 0.110 |
Why?
|
| Calcification, Physiologic | 1 | 2014 | 170 | 0.110 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 732 | 0.110 |
Why?
|
| Lipopolysaccharides | 5 | 2023 | 2205 | 0.110 |
Why?
|
| Peri-Implantitis | 1 | 2015 | 116 | 0.110 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 575 | 0.110 |
Why?
|
| Leukotriene B4 | 3 | 2011 | 280 | 0.100 |
Why?
|
| Dental Implantation, Endosseous | 2 | 2014 | 531 | 0.100 |
Why?
|
| Stomatitis | 1 | 2015 | 271 | 0.100 |
Why?
|
| Apoptosis | 4 | 2017 | 9468 | 0.100 |
Why?
|
| RNA Precursors | 1 | 2013 | 212 | 0.100 |
Why?
|
| Metformin | 1 | 2020 | 905 | 0.100 |
Why?
|
| Root Planing | 4 | 2014 | 71 | 0.100 |
Why?
|
| Hyperoxia | 1 | 2014 | 258 | 0.100 |
Why?
|
| Neuroprotective Agents | 1 | 2019 | 957 | 0.100 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2013 | 412 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2021 | 579 | 0.100 |
Why?
|
| Bone Regeneration | 1 | 2014 | 432 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2019 | 3439 | 0.100 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 2 | 2009 | 97 | 0.100 |
Why?
|
| Bone Remodeling | 1 | 2015 | 581 | 0.100 |
Why?
|
| Molecular Typing | 1 | 2012 | 116 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2024 | 4369 | 0.100 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2011 | 1389 | 0.100 |
Why?
|
| Stem Cells | 2 | 2023 | 3522 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 3874 | 0.090 |
Why?
|
| Insulin Resistance | 2 | 2023 | 3956 | 0.090 |
Why?
|
| Calcium Phosphates | 1 | 2012 | 171 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2019 | 1805 | 0.090 |
Why?
|
| Ultrasonic Therapy | 1 | 2012 | 215 | 0.090 |
Why?
|
| Interleukin-10 | 4 | 2012 | 1176 | 0.090 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2010 | 141 | 0.090 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2011 | 143 | 0.090 |
Why?
|
| Cholecalciferol | 1 | 2015 | 552 | 0.090 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 5 | 2009 | 221 | 0.090 |
Why?
|
| Aged | 18 | 2024 | 168840 | 0.090 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 1626 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2021 | 2725 | 0.080 |
Why?
|
| Peptides | 2 | 2020 | 4338 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2021 | 3414 | 0.080 |
Why?
|
| Erythrocytes | 2 | 2016 | 2417 | 0.080 |
Why?
|
| Nanostructures | 1 | 2014 | 552 | 0.080 |
Why?
|
| Bicuspid | 1 | 2009 | 69 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2016 | 4355 | 0.080 |
Why?
|
| Ceruloplasmin | 1 | 2009 | 57 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2007 | 1649 | 0.080 |
Why?
|
| Lung Injury | 1 | 2014 | 422 | 0.080 |
Why?
|
| Phosphates | 1 | 2013 | 770 | 0.080 |
Why?
|
| Receptor Cross-Talk | 1 | 2009 | 116 | 0.080 |
Why?
|
| Dinoprostone | 2 | 2013 | 597 | 0.080 |
Why?
|
| Epithelial Cells | 3 | 2017 | 3661 | 0.080 |
Why?
|
| Eubacterium | 3 | 2014 | 23 | 0.080 |
Why?
|
| Tomography, Optical Coherence | 1 | 2022 | 2907 | 0.080 |
Why?
|
| Alzheimer Disease | 2 | 2021 | 8579 | 0.080 |
Why?
|
| Metagenome | 1 | 2012 | 450 | 0.080 |
Why?
|
| Alternative Splicing | 1 | 2013 | 1091 | 0.080 |
Why?
|
| Mice | 12 | 2023 | 81402 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 2137 | 0.080 |
Why?
|
| Respiratory Burst | 1 | 2008 | 110 | 0.080 |
Why?
|
| Blood Glucose | 2 | 2020 | 6380 | 0.070 |
Why?
|
| Actinomyces | 2 | 2021 | 40 | 0.070 |
Why?
|
| Anti-Infective Agents | 2 | 2012 | 984 | 0.070 |
Why?
|
| Protein Kinase C | 3 | 2010 | 1202 | 0.070 |
Why?
|
| Reference Values | 1 | 2015 | 4921 | 0.070 |
Why?
|
| Esterification | 1 | 2007 | 39 | 0.070 |
Why?
|
| Leukocytes | 1 | 2015 | 2024 | 0.070 |
Why?
|
| Metabolic Diseases | 1 | 2014 | 681 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 3076 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 3 | 2021 | 6206 | 0.070 |
Why?
|
| Materials Testing | 1 | 2011 | 864 | 0.070 |
Why?
|
| Gene Expression Profiling | 4 | 2023 | 9410 | 0.070 |
Why?
|
| Up-Regulation | 4 | 2013 | 4116 | 0.070 |
Why?
|
| Calcium | 3 | 2015 | 5726 | 0.070 |
Why?
|
| Immunity, Mucosal | 1 | 2010 | 482 | 0.070 |
Why?
|
| T-Lymphocytes | 3 | 2024 | 10188 | 0.070 |
Why?
|
| Virulence | 2 | 2021 | 1301 | 0.070 |
Why?
|
| Diglycerides | 2 | 2005 | 177 | 0.070 |
Why?
|
| Macrophages | 3 | 2015 | 5764 | 0.070 |
Why?
|
| Phosphatidate Phosphatase | 2 | 2021 | 20 | 0.070 |
Why?
|
| Immunoglobulin A | 1 | 2010 | 980 | 0.070 |
Why?
|
| Connective Tissue Cells | 1 | 2006 | 49 | 0.070 |
Why?
|
| Doxycycline | 1 | 2009 | 344 | 0.070 |
Why?
|
| Receptors, Immunologic | 3 | 2008 | 1411 | 0.070 |
Why?
|
| Aspirin | 3 | 2017 | 3134 | 0.070 |
Why?
|
| HL-60 Cells | 3 | 2013 | 363 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2007 | 10759 | 0.060 |
Why?
|
| Case-Control Studies | 9 | 2017 | 22097 | 0.060 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2006 | 365 | 0.060 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 1674 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3777 | 0.060 |
Why?
|
| Aging | 2 | 2024 | 8689 | 0.060 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2010 | 736 | 0.060 |
Why?
|
| Kuwait | 2 | 2016 | 92 | 0.060 |
Why?
|
| Adolescent | 11 | 2022 | 88196 | 0.060 |
Why?
|
| Pilot Projects | 4 | 2022 | 8611 | 0.060 |
Why?
|
| Cell Proliferation | 5 | 2023 | 10425 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2012 | 6230 | 0.060 |
Why?
|
| Models, Animal | 1 | 2011 | 2111 | 0.060 |
Why?
|
| Platelet-Rich Plasma | 1 | 2007 | 178 | 0.060 |
Why?
|
| Tooth Bleaching | 1 | 2004 | 10 | 0.060 |
Why?
|
| Tooth Discoloration | 1 | 2004 | 15 | 0.060 |
Why?
|
| Bone Density | 2 | 2015 | 3549 | 0.060 |
Why?
|
| Chronic Disease | 4 | 2024 | 9309 | 0.060 |
Why?
|
| Starvation | 1 | 2024 | 141 | 0.060 |
Why?
|
| Genes, Bacterial | 2 | 2021 | 1079 | 0.060 |
Why?
|
| Cell Differentiation | 5 | 2023 | 11526 | 0.060 |
Why?
|
| Sodium Fluoride | 1 | 2004 | 65 | 0.060 |
Why?
|
| Polymers | 1 | 2011 | 1615 | 0.060 |
Why?
|
| Dental Caries Susceptibility | 1 | 2023 | 26 | 0.060 |
Why?
|
| Immediate-Early Proteins | 1 | 2006 | 449 | 0.060 |
Why?
|
| Gingival Pocket | 1 | 2023 | 7 | 0.060 |
Why?
|
| Metagenomics | 2 | 2020 | 466 | 0.050 |
Why?
|
| Chemokine CXCL1 | 1 | 2023 | 101 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 11070 | 0.050 |
Why?
|
| Bacterial Typing Techniques | 1 | 2004 | 264 | 0.050 |
Why?
|
| Mice, Obese | 2 | 2014 | 420 | 0.050 |
Why?
|
| Gingival Hemorrhage | 2 | 2014 | 49 | 0.050 |
Why?
|
| Bacterial Load | 2 | 2013 | 151 | 0.050 |
Why?
|
| Klebsiella Infections | 1 | 2024 | 148 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2010 | 1805 | 0.050 |
Why?
|
| Risk Factors | 6 | 2024 | 74055 | 0.050 |
Why?
|
| Flow Cytometry | 4 | 2016 | 5865 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 4 | 2024 | 7424 | 0.050 |
Why?
|
| Klebsiella pneumoniae | 1 | 2024 | 256 | 0.050 |
Why?
|
| Chromatography, Liquid | 2 | 2019 | 983 | 0.050 |
Why?
|
| Nasal Cavity | 1 | 2024 | 304 | 0.050 |
Why?
|
| Prospective Studies | 6 | 2023 | 54339 | 0.050 |
Why?
|
| Angiopoietins | 1 | 2022 | 85 | 0.050 |
Why?
|
| Tetracycline | 2 | 2013 | 219 | 0.050 |
Why?
|
| Radiography | 2 | 2020 | 6963 | 0.050 |
Why?
|
| Drug Combinations | 3 | 2013 | 2043 | 0.050 |
Why?
|
| Propionibacteriaceae | 1 | 2021 | 10 | 0.050 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 15476 | 0.050 |
Why?
|
| Mouth Diseases | 1 | 2024 | 242 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2007 | 1174 | 0.050 |
Why?
|
| 20-Hydroxysteroid Dehydrogenases | 1 | 2021 | 6 | 0.050 |
Why?
|
| Incidence | 1 | 2020 | 21322 | 0.050 |
Why?
|
| Prevotella | 2 | 2013 | 80 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2010 | 3108 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2003 | 637 | 0.050 |
Why?
|
| Phosphorylation | 5 | 2014 | 8311 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2005 | 1250 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 2007 | 2444 | 0.050 |
Why?
|
| Bacteroides | 2 | 2013 | 166 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2014 | 12785 | 0.050 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2021 | 174 | 0.050 |
Why?
|
| Enzyme Activation | 3 | 2014 | 3592 | 0.050 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 26063 | 0.040 |
Why?
|
| Nose | 1 | 2024 | 521 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2005 | 1511 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2014 | 472 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2004 | 728 | 0.040 |
Why?
|
| Radiography, Bitewing | 1 | 2020 | 35 | 0.040 |
Why?
|
| Brazil | 2 | 2020 | 1224 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2022 | 629 | 0.040 |
Why?
|
| Oral Surgical Procedures | 2 | 2012 | 166 | 0.040 |
Why?
|
| Cell Membrane | 3 | 2017 | 3685 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2014 | 476 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 1 | 2022 | 597 | 0.040 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2021 | 305 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 3631 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2024 | 823 | 0.040 |
Why?
|
| Diphosphonates | 2 | 2019 | 636 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2015 | 613 | 0.040 |
Why?
|
| Body Mass Index | 4 | 2023 | 12932 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2023 | 870 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 2453 | 0.040 |
Why?
|
| Collagen | 2 | 2021 | 2637 | 0.040 |
Why?
|
| Treatment Outcome | 6 | 2017 | 64591 | 0.040 |
Why?
|
| Insulin | 3 | 2022 | 6591 | 0.040 |
Why?
|
| Collagen Type I | 2 | 2015 | 616 | 0.040 |
Why?
|
| Epithelium | 1 | 2023 | 1603 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 2860 | 0.040 |
Why?
|
| Phenytoin | 2 | 2010 | 189 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2003 | 2382 | 0.040 |
Why?
|
| Salivary Glands | 1 | 2019 | 229 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2010 | 2419 | 0.040 |
Why?
|
| Receptors, Death Domain | 1 | 2017 | 31 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 13312 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2020 | 23953 | 0.040 |
Why?
|
| Germany | 1 | 2020 | 873 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 11900 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 2 | 2021 | 1959 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2021 | 857 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2010 | 3405 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2019 | 901 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2024 | 1726 | 0.030 |
Why?
|
| Dental Care | 1 | 2019 | 285 | 0.030 |
Why?
|
| Blotting, Western | 3 | 2009 | 5031 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 2 | 2016 | 1454 | 0.030 |
Why?
|
| Cognition | 2 | 2024 | 6973 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2020 | 790 | 0.030 |
Why?
|
| Cisplatin | 1 | 2022 | 1647 | 0.030 |
Why?
|
| Nifedipine | 2 | 2007 | 221 | 0.030 |
Why?
|
| Neutrophil Activation | 2 | 2009 | 180 | 0.030 |
Why?
|
| Time Factors | 4 | 2011 | 39947 | 0.030 |
Why?
|
| Leptin | 2 | 2014 | 1593 | 0.030 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2015 | 82 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2021 | 1254 | 0.030 |
Why?
|
| Neoplasms | 1 | 2024 | 22083 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2015 | 91 | 0.030 |
Why?
|
| Dental Cementum | 1 | 2014 | 53 | 0.030 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2015 | 146 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2019 | 703 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2004 | 9639 | 0.030 |
Why?
|
| Protein Isoforms | 2 | 2013 | 1697 | 0.030 |
Why?
|
| Caspases | 1 | 2017 | 876 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2021 | 2911 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2017 | 1178 | 0.030 |
Why?
|
| Biota | 1 | 2013 | 23 | 0.030 |
Why?
|
| Child | 6 | 2022 | 80086 | 0.030 |
Why?
|
| Treponema denticola | 1 | 2013 | 13 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2022 | 2485 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 2015 | 1084 | 0.030 |
Why?
|
| DNA, Bacterial | 2 | 2012 | 1481 | 0.030 |
Why?
|
| Capnocytophaga | 1 | 2013 | 26 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2015 | 208 | 0.030 |
Why?
|
| Stomatitis, Aphthous | 1 | 1994 | 51 | 0.030 |
Why?
|
| Fusobacterium | 1 | 2013 | 54 | 0.030 |
Why?
|
| Triamcinolone Acetonide | 1 | 1994 | 100 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2021 | 1406 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2018 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 2852 | 0.030 |
Why?
|
| Biomimetic Materials | 1 | 2014 | 172 | 0.030 |
Why?
|
| Body Weight | 2 | 2014 | 4614 | 0.030 |
Why?
|
| Concanavalin A | 1 | 2012 | 190 | 0.030 |
Why?
|
| Streptococcus | 1 | 2013 | 198 | 0.030 |
Why?
|
| Follow-Up Studies | 5 | 2014 | 39078 | 0.030 |
Why?
|
<